|
|||||
|
|
SWOG S0722: Phase II Study of mTOR Inhibitor Everolimus (RAD001) in Advanced Malignant Pleural Mesothelioma (MPM) |
|
| Affiliation: | 2. SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA;3. Department of Medicine, Arizona Cancer Center, University of Arizona Tucson School of Medicine, Tucson, AZ;4. Department of Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, CA;5. Department of Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX |
| Abstract: | |
| Keywords: | Malignant pleural mesothelioma mTOR inhibitor Everolimus Modified RECIST |
| 本文献已被 ScienceDirect 等数据库收录！ | |